1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Evidence for AI in Health (EVAH) initiative is a $60 million joint investment by the Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust to support rigorous, country-led evaluations of AI health tools in low- and middle-income countries.
Delivered in partnership with J-PAL and the African Population and Health Research Center, EVAH funds evaluations of AI-enabled clinical decision support tools in primary and community healthcare settings across Sub-Saharan Africa, South Asia, and Southeast Asia. Pathway A supports early-deployment evaluations focusing on usability, workflow integration, and safety for up to $1 million.
Pathway B funds randomized controlled trials, economic analyses, and implementation science studies of tools ready for deployment at scale for up to $3 million. The initiative addresses a critical evidence gap about whether AI diagnostic and clinical decision support tools actually improve health outcomes in resource-limited settings.
Get alerted about grants like this
Get emailed when new opportunities from “Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofits, for-profit companies, international organizations, government agencies, academic institutions, and collaborations. Proposals must be led by institutions based in Sub-Saharan Africa, South Asia, or Southeast Asia. Applicants must have access to operational AI-enabled clinical decision support tools ready for real-world use in primary healthcare. Confirm the full requirements in the official notice before applying.
The current listing shows $60 million total joint investment over three years. Pathway A (early-stage evaluation) awards up to $1 million per project. Pathway B (scale-ready impact evaluation) awards up to $3 million per project. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
EVAH Evidence for AI in Health Initiative for Evaluating AI Clinical Decision Support in Low and Middle Income Countries is funded by Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
MacKenzie Scott's Yield Giving has moved more than $26 billion — including roughly $7 billion in 2025, over a third of all U.S. megagifts — through unrestricted, trust-based grants with no application. Melinda French Gates's Pivotal Ventures has committed $2 billion to women's health and economic power. The Bezos philanthropies have moved billions more. As the Buffett–Gates era winds down, this new class of megadonor is rewriting the rules of major giving. Here is what changes for nonprofits, and how to become the kind of organization this money finds.
Read articleGates committed $540.2 million over a decade to the Institute for Health Metrics and Evaluation — the largest gift in University of Washington history — while IHME's federal grant income falls from $7.3 million to a projected $4.8 million. The gift is a case study in the anchor-funder model: what it can do that federal money cannot, and the concentration risk it quietly underwrites.
Read articleOn July 14, 2026, Warren Buffett routed his roughly $6 billion annual Berkshire gift to four family foundations and excluded the Gates Foundation — the first exclusion since 2006, pending a review of the foundation's historical ties to Jeffrey Epstein. Buffett has given the Gates Foundation more than $43 billion over two decades. Here is why the pause matters for the world's largest grantmaker, what it reveals about concentration risk in modern philanthropy, and what nonprofits that depend on a single major funder should do now.
Read article